Indication :
Epirubicin HCl administered as single agent has shown to produce regression in a broad spectrum of tumors including mammary carcinoma, malignant lymphomas, soft tissue sarcomas and gastric cancer. Preliminary findings indicate that the drug has produce some anti tumor activity in malignant melanoma and in advanced colorectal carcinoma. Given in combination with other antiblastic drugs, Epirubicin HCl has induced also a therapeutic response in lung and ovarian cancer.
Compositions :
Each mL Epirubicin hydrochloride 2 mg
Storage Condition :
Store in refrigerator (2 – 8°C), protect from light. Keep medicine out of reach of children.
